Acadian Asset Management LLC Centogene N.V. Transaction History

Acadian Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.0 - $1.64 $6,793 - $11,140	-6,793 Reduced 21.57%	24,703 $28,000
Q2 2023 Aug 07, 2023	SELL	$0.63 - $1.63 $8,768 - $22,686	-13,918 Reduced 30.65%	31,496 $47,000
Q1 2023 May 11, 2023	SELL	$0.65 - $1.43 $4,508 - $9,918	-6,936 Reduced 13.25%	45,414 $28,000
Q4 2022 Feb 14, 2023	SELL	$0.72 - $1.28 $1,966 - $3,495	-2,731 Reduced 4.96%	52,350 $47,000
Q3 2022 Nov 14, 2022	SELL	$1.11 - $2.78 $6,157 - $15,420	-5,547 Reduced 9.15%	55,081 $60,000
Q2 2022 Aug 09, 2022	SELL	$2.06 - $4.25 $16,043 - $33,099	-7,788 Reduced 11.38%	60,628 $144,000
Q1 2022 May 12, 2022	SELL	$3.3 - $5.44 $7,619 - $12,560	-2,309 Reduced 3.26%	68,416 $285,000
Q4 2021 Feb 10, 2022	BUY	$4.56 - $10.56 $44,934 - $104,058	9,854 Added 16.19%	70,725 $366,000
Q3 2021 Nov 12, 2021	BUY	$9.9 - $11.72 $241,183 - $285,522	24,362 Added 66.73%	60,871 $666,000
Q2 2021 Aug 11, 2021	BUY	$9.02 - $12.93 $329,311 - $472,061	36,509 New	36,509 $380,000

33.6K

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $2.98M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.